A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease

Chemico-Biological Interactions

Volumn 105, Issue 3, 1997, Pages 199-228

  Recanatini, M ^a   Cavalli, A ^a   Hansch, C ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b POMONA COLLEGE   (United States)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Computer assisted drug design; Enzyme inhibition; QSAR; Structure activity relationships

Indexed keywords

BENZYLAMINE DERIVATIVE; CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE DERIVATIVE; TACRINE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; COMPUTER AIDED DESIGN; ENZYME INHIBITION; HYDROPHOBICITY; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINESTERASE; ACRIDINES; ALZHEIMER DISEASE; ANIMALS; BENZYLAMINES; BRAIN; CHOLINESTERASE INHIBITORS; DRUG DESIGN; ELECTROPHORUS; ERYTHROCYTES; HUMANS; MATHEMATICS; MICE; MOLECULAR STRUCTURE; PHYSOSTIGMINE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031214592     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00047-1     Document Type: Article

References (40)

1. [1] J. Varghese, I. Lieberburg, E.D. Thorsett, Alzheimer's disease: current therapeutic approaches. Annu. Rep. Med. Chem. 28 (1993) 197-206.
2. [2] D.B. Schenk, R.E. Rydel, P. May, S. Little, J. Panetta, I. Lieberburg, S. Sinha, Therapeutic approaches related to amyloid-β peptide and Alzheimer's disease, J. Med. Chem. 38 (1995) 4141-4154.
3. [3] R.T. Bartus, L.D. Dean III, B. Beer. A.S. Lippa. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-417.
4. [4] F. Gualtieri, S. Dei. D. Manetti, M.N. Romanelli, S. Scapecchi, E. Teodori. The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis. II Farmaco 50 (1995) 489-503.
5. K, Drugs Fut. 18 (1993) 1091-1093.
6. [6] A.D. Elbein, Hydrolases, in: C. Hansch (Ed.), Comprehensive Medicinal Chemistry. vol. 2, Pergamon Press. Oxford, 1990, pp. 365-389.
7. [7] T.R. Fukuto, R.L. Metcalf, Structure and insecticidal activity of some diethyl-substituted phenyl phosphates. J. Agric. Food Chem. 4 (1956) 930-935.
8. [8] C. Hansch, Quantitative structure-activity relationships and the unnamed science, Accounts Chem. Res. 26 (1993) 147-153.
9. [9] C. Hansch, A. Leo, Exploring QSAR. Fundamentals and Applications in Chemistry and Biology, American Chemical Society, Washington, DC, 1995.
10. [10] C. Hansch, Comparative quantitative structure-activity relationship. Insect versus vertebrate cholinesterase, in: C.N. Reynolds, M.K. Holloway, A.K. Cox (Eds.), Computer Aided Molecular Design. Applications in Agrochemicals, Materials and Pharmaceuticals, ACS Symposium Series 589, American Chemical Society, Washington, DC, 1995, pp. 281-291.
11. [11] S.P. Gupta, QSAR studies on enzyme inhibitors, Chem. Rev. 87 (1987) 1183-1253.
12. [12] P.S. Magee, Chemicals affecting insects and mites, in: J.G. Topliss (Ed.), Quantitative Structure-Activity Relationships of Drugs, Academic Press, New York, 1983, pp. 393-436.
13. [13] C-QSAR, Ver. 1.87, BioByte, Claremont, CA, 1994.
14. [14] C. Hansch, A. Leo, Exploring QSAR. Fundamentals and Applications in Chemistry and Biology, American Chemical Society, Washington, DC, 1995 (Chapter 5).
15. [15] C. Hansch, A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley-Interscience, New York, 1979.
16. [16] N.H. Greig, X.-H. Pei, T.T. Soncrant, D.K. Ingram, A. Brossi, Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease, Med. Res. Rev. 15 (1995) 3-31.
17. [17] M.A. Alisi, M. Brufani, L. Filocamo, G. Gostoli, E. Licandro, M.C. Cesta, S. Lappa, D. Marchesini, P. Pagella, Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: morpholinoalkylcarbamoyloxyeseroline derivatives. Bioorg. Med. Chem. Lett. 5 (1995) 2077-2080.
18. 1-norphysostigmine, (-)-eseramine and other N(1)-substituted analogues of (-)-physostigmine, J. Med. Chem. 31 (1988) 2297-2300.
19. 1-noreseroline and (-)-physovenol: selective inhibitors of acetyl and, or butyrylcholinesterase, Med. Chem. Res. 2 (1992) 238-246.
20. [20] Y.L. Chen, J. Nielsen, K. Hedberg, A. Dunaiskis, S. Jones, L. Russo, J. Johnson, J. Ives, D. Liston, Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues, J. Med. Chem. 35 (1992) 1429-1434.
21. [21] G.M. Steinberg, M.L. Mednick, J. Maddox, R. Rice, A hydrophobic binding site in acetylcholinesterase, J. Med. Chem. 18 (1975) 1056-1061.
22. [22] G.M. Shutske, F.A. Pierrat, K.J. Kapples, M.L. Cornfeldt, M.R. Szewczak, F.P. Huger, G.M. Bores, V. Haroutunian, K.L. Davis, 9-amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics, J. Med. Chem. 32 (1989) 1805-1813.
23. [23] Y. Ishihara, K. Kato, G. Goto, Central cholinergic agents. I. Potent acetylcholinesterase inhibitors, 2-[ω-[N-alkyl-N-(ω-phenyl-alkyl)amino]alkyl]-1H-isoindole-1,3(2H)-diones, based on a new hypothesis of the enzyme's active site, Chem. Pharm. Bull. 39 (1991) 3225-3235.
24. [24] Y. Ishihara, K. Kato, G. Goto, Central cholinergic agents. II. Synthesis and acetylcholinesterase inhibitory activities of N-[ω-[N-alkyl-N-(phenylmethyl)amino]alkyl]-3-arylpropenamides, Chem. Pharm. Bull. 39 (1991) 3236-3243.
25. [25] J.-L. Vidaluc, F. Calmel, D.C.H. Bigg, E. Carilla, M. Briley, Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluation, J. Med. Chem. 38 (1995) 2969-2973.
26. [26] H. Sugimoto, Y. Tsuchiya, H. Sugumi, K. Higurashi, N. Karibe, Y. Iimura, A. Sasaki, Y. Kawakami, T. Nakamura, S. Araki, Y. Yamanishi, K. Yamatsu, Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives, J. Med. Chem. 33 (1990) 1880-1887.
27. [27] H. Sugimoto, Y. Tsuchiya, H. Sugumi, K. Higurashi, N. Karibe, Y. Iimura, A. Sasaki, S. Araki, Y. Yamanishi, K. Yamatsu, Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives, J. Med. Chem. 35 (1992) 4542-4548.
28. [28] A. Villalobos, J.F. Blake, C.K. Biggers, T.W. Butler, D.S. Chapin, Y.L. Chen, J.L. Ives, S.B. Jones, D.R. Liston, A.A. Nagel, D.M. Nason, J.A. Nielsen, I.A. Shalaby, W. Frost White, Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase, J. Med. Chem. 37 (1994) 2721-2733.
29. [29] J.-L. Vidaluc, F. Calmel, D.C.H. Bigg, E. Carilla, A. Stenger, P. Chopin, M. Briley, Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and anti-acetylcholinesterase activity, J. Med. Chem. 37 (1994) 689-695.
30. [30] J.L. Sussman, M. Harel, F. Frolow, C. Oefner, A. Goldman, L. Toker, I. Silman, Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein, Science 253 (1991) 872-879.
31. [31] J.L. Sussman, M. Harel, I. Silman. Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs, Chem.-Biol. Interact. 87 (1993) 187-197.
32. [32] Y.-P. Pang, A.J. Kozikowski. Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies, J. Comp.-Aided Mol. Des. 8 (1994) 669-681.
33. [33] Y.-P. Pang, A.J. Kozikowski, Prediction of the binding site of 1-benzyl-4-[(5.6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program, J. Comp.-Aided Mol. Des. 8 (1994) 683-693.
34. R, Drugs Fut. 19 (1994) 709-710.
35. [35] M. Recanatini, T. Klein, C.-Z. Yang, J. McClarin, R. Langridge, C. Hansch, Quantitative structure-activity relationships and molecular graphics in ligand-receptor interactions: amidine inhibition of trypsin, Mol. Pharmacol. 29 (1986) 436-446.
36. [36] Z. Radic, E. Reiner, P. Taylor, Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. Mol. Pharmacol. 39 (1991) 98-104.
37. [37] E-2020, Drugs Fut., 18 (1993) 77-78.
38. [38] W. Tong, E.R. Collantes, Y. Chen. W.J. Welsh, A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors, J. Med. Chem. 39 (1996) 380-387.
39. [39] M.G. Cardozo, Y. Iimura, H. Sugimoto, Y. Yamanishi, A.J. Hopfinger, QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase, J. Med. Chem. 35 (1992) 584-589.
40. [40] M.G. Cardozo, T. Kawai, Y. Iimura, H. Sugimoto, Y. Yamanishi, A.J. Hopfinger. Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase. J. Med. Chem. 35 (1992) 590-601.